Home > Income Statement > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Profit After Tax

    Back to Income Statement
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Profit After Tax History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit After Tax ₹15 Cr₹15 Cr₹1,212,944 Cr₹13 Cr₹12 Cr

What is the latest Profit After Tax of MEDICAMEN BIOTECH ?

The latest Profit After Tax ratio of MEDICAMEN BIOTECH is ₹15 Cr based on Mar2024 Consolidated results.
Year Profit After Tax
Mar2024₹15 Cr
Mar2023₹15 Cr
Mar2022₹1,212,944 Cr
Mar2021₹13 Cr
Mar2020₹12 Cr

How is Profit After Tax of MEDICAMEN BIOTECH Trending?

Years Profit After Tax % Change
Mar2024 ₹15 Cr
-1.13
Mar2023 ₹15 Cr
-100.00
Mar2022 ₹1,212,944 Cr
9,125,955.15
Mar2021 ₹13 Cr
10.52
Mar2020 ₹12 Cr -

Compare Profit After Tax of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹475.7 Cr -1.4% -14% -8.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,192.0 Cr 1.2% -4.2% -5.7% Stock Analytics
DIVIS LABORATORIES ₹161,479.0 Cr 3% -9.1% 31.5% Stock Analytics
CIPLA ₹125,113.0 Cr 4.1% 5.5% -0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹123,539.0 Cr 1.1% 4.3% 8.2% Stock Analytics
DR REDDYS LABORATORIES ₹103,926.0 Cr 3.7% 0.1% -7.4% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-1.4%

-14%

-8.3%

SENSEX

1.3%

-0.8%

3.2%


You may also like the below Video Courses